Nabriva Therapeutics (NASDAQ:NBRV) Now Covered by StockNews.com
StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Trading Down 100.0 % The firm has a market capitalization of $45.46 million, a price-to-earnings ratio of 0.00 and a […]
StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Trading Down 100.0 % The firm has a market capitalization of $45.46 million, a price-to-earnings ratio of 0.00 and a […]
